Email

info@tabeebakhealthcare.com

Patient Service

+90 501 333 73 73

Prof. Dr. Baykal Tülek

/

Prof. Dr. Baykal Tülek

Prof. Dr. Baykal Tülek Pulmonologist in Istanbul

Prof. Dr. Baykal Tülek

Work Hospitals

Medical Interests

Doctor Details

Prof. Dr. Baykal Tülek

Prof. Dr. Baykal Tülek is a specialist in pulmonology with extensive academic and scientific experience in the diagnosis and follow-up of respiratory system diseases.

Throughout his career, he has combined academic work at Selcuk University Faculty of Medicine with specialization in pulmonology, in addition to research contributions on important topics such as pulmonary fibrosis, bronchiectasis, COVID-19, and the gut microbiome in patients with idiopathic pulmonary fibrosis.

He provides his medical services within Acibadem Healthcare Group at Acibadem Kadikoy Dr. Sinasi Can Hospital, drawing on his scientific and research experience to support precise and comprehensive medical care for patients with respiratory diseases.

Education and Academic Experience

  • 2014 – 2019 — Selcuk University Faculty of Medicine, Department of Pulmonology / Associate Professor
  • 2014 — Selcuk University Faculty of Medicine, Department of Pulmonology / Professor
  • 2006 – 2014 — Selcuk University Faculty of Medicine, Department of Pulmonology / Assistant Professor
  • 1999 — Istanbul University, Istanbul Faculty of Medicine / Pulmonology Specialization
  • 1994 — Istanbul University, Istanbul Faculty of Medicine

Professional Experience of Prof. Dr. Baykal Tülek

  • 2026 — Acibadem Healthcare Group

Scientific Publications

  • The Role of Serum Prolidase Activity, MMP-1, MMP-7, and TGF-ß Values in the Prediction of Early Fibrosis in Patients with Moderate to Severe COVID-19
    2025; 17(7):954. doi:10.3390/v17070954
    Doğu Zengin D, Ergün D, Yormaz B, Ergün R, Güven H, Körez Muslu K, Özer H, Ünlü A, Tülek B, Kanat F.
  • Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
    New England Journal of Medicine. 2025; 392. doi:10.1056/NEJMoa2411664
    Chalmers JD, Burgel PR, Daley CL, De Soyza A, Haworth CS, Mauger D, Loebinger MR, McShane PJ, Ringshausen FC, Blasi F, and others; ASPEN Investigators.
  • Gut Microbiota Profiles of Patients with Idiopathic Pulmonary Fibrosis
    Experimental Lung Research. 2024; 50. doi:10.1080/01902148.2024.2437377
    Göktürk K, Tülek B, Kanat F, Maçin S, Arslan U, Shahbazova M, Göktürk Ö.
  • Spontaneous Pneumomediastinum in a COVID-19 Patient: A Case Report
    Journal of Contemporary Medicine. 2022; 12(1):159-161. doi:10.16899/jcm.978752
    Ergün D, Ergün R, Atalay NA, Kanat F, Tülek B, Yormaz B.
  • Correlation of Myeloid-Derived Suppressor Cells with C-Reactive Protein, Ferritin, and Lactate Dehydrogenase Levels in Patients with Severe COVID-19
    Scandinavian Journal of Immunology. 2022; 95(1):e13108. doi:10.1111/sji.13108
    Emsen A, Sümer Ş, Prof. Dr. Baykal Tülek, Akay Çizmecioğlu H, Vatansev H, Göktepe MH, Kanat F, Köksal Y, Arslan U, Artaç H.